SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Cymer (CYMI) -- Ignore unavailable to you. Want to Upgrade?


To: FJB who wrote (24390)3/2/2000 1:33:00 AM
From: Gemini  Respond to of 25960
 
Robert,

I thought I had seen the SPIE press release, but I wasn't sure.

IBM was down today despite the conference and Cymer roared ahead on very good volume. Go figure!!!

Either analysts don't believe IBM's technology will be a reality in the marketplace anytime soon (meaning within two years) or they cannot think ahead more than a couple of quarters if their lives depended upon it, or both???

Allan



To: FJB who wrote (24390)3/2/2000 2:15:00 AM
From: TI2, TechInvestorToo  Respond to of 25960
 
PREVAIL is the IBM/Nikon version of ASML/LUCENT/AMAT Scalpel (eLITH) approach. Consensus appears to be that 248nm exposure will be the 130nm generation approach. 193 commercial exposures are still 18mos+ away. Then we wait for 157. Projection ebeam seems to be shut out till 50nm generation (at least).
Good luck LONGS
TI2